Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127162071 | 12716207 | 1 | I | 20160822 | 20160906 | 20160906 | EXP | CA-ORION CORPORATION ORION PHARMA-TREX2016-1611 | ORION | 0.00 | M | Y | 0.00000 | 20160906 | MD | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127162071 | 12716207 | 1 | PS | METHOTREXATE (TRADE NAME UNKNOWN) | METHOTREXATE | 1 | Unknown | U | 0 | ||||||||||
127162071 | 12716207 | 2 | SS | ENBREL | ETANERCEPT | 1 | Unknown | U | 0 | ||||||||||
127162071 | 12716207 | 3 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | U | 0 | ||||||||||
127162071 | 12716207 | 4 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | U | 0 | ||||||||||
127162071 | 12716207 | 5 | SS | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | Unknown | U | 0 | ||||||||||
127162071 | 12716207 | 6 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | U | 0 | TABLET | |||||||||
127162071 | 12716207 | 7 | SS | ORENCIA | ABATACEPT | 1 | Unknown | U | 0 | ||||||||||
127162071 | 12716207 | 8 | SS | REMICADE | INFLIXIMAB | 1 | Unknown | U | 0 | ||||||||||
127162071 | 12716207 | 9 | SS | RITUXAN | RITUXIMAB | 1 | Unknown | U | 0 | ||||||||||
127162071 | 12716207 | 10 | SS | ZOSTAVAX | VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN | 1 | Unknown | U | 0 | ||||||||||
127162071 | 12716207 | 11 | C | XELJANZ | TOFACITINIB CITRATE | 1 | Unknown | 0 | |||||||||||
127162071 | 12716207 | 12 | C | CORTISONE | CORTISONEHYDROCORTISONE | 1 | Unknown | 0 | |||||||||||
127162071 | 12716207 | 13 | C | DICLOFENAC | DICLOFENAC | 1 | Unknown | 0 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127162071 | 12716207 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127162071 | 12716207 | Alopecia | |
127162071 | 12716207 | Drug ineffective | |
127162071 | 12716207 | Drug intolerance | |
127162071 | 12716207 | Lymphoma | |
127162071 | 12716207 | Neoplasm malignant | |
127162071 | 12716207 | Onychoclasis | |
127162071 | 12716207 | Tooth loss |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |